American Board Of Family Medicine (ABFM) Practice Exam

For acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD), the use of corticosteroids such as prednisone is a common practice to reduce inflammation and improve airflow. The choice of dose and duration is critical in managing exacerbations effectively. Prescribing prednisone at 40 mg daily for 5 days is an appropriate intervention for acute exacerbations as it allows a higher anti-inflammatory effect compared to lower doses. This regimen helps to quickly address the inflammation associated with a COPD exacerbation, facilitating recovery and potentially reducing the severity and duration of the episode. While the lower doses or short durations of treatment may provide some benefit, using a higher dose for a limited time is generally more effective in managing acute exacerbations. The guideline to use systemic corticosteroids in such cases supports this approach, emphasizing that a standard 5-day course of higher-dose oral corticosteroids can lead to significant improvement in symptoms and lung function. Other options, such as an albuterol nebulizer treatment, would provide bronchodilation to relieve acute symptoms but do not adequately address the inflammatory component of COPD exacerbations. Similarly, an ICS/LABA combination inhaler is typically used for maintenance therapy rather than for the acute management of exacerbations. Therefore, the use of a higher-dose